Atenolol versus losartan in children and young adults with Marfan's syndrome.
New England Journal of Medicine.
Times cited: 238
Surgical Treatment of Patients Enrolled in the National Registry of Genetically Triggered Thoracic Aortic Conditions.
Annals of Thoracic Surgery.
Times cited: 19
Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.
American Heart Journal.
Times cited: 191